Prof. Gaofeng Li 李高峰
Chief Physician, Professor
Department of Thoracic Surgery II, Yunnan Cancer Hospital, Kunming
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Comprehensive treatment of chest tumors, including benign and malignant lung, esophageal, and mediastinal tumors. Specializes in minimally invasive surgical treatment for lung and esophageal cancer.
Dr. Li is a Professor and Chief Physician with 37 years of experience in thoracic tumor surgery. Currently Vice President of Yunnan Cancer Hospital, Dr. Li focuses on basic research and individualized minimally invasive treatments. Dr. Li was among the first in Yunnan to perform minimally invasive thoracic surgeries and has presented at over 110 academic conferences.
Professional roles
- Chair, Yunnan Medical Association Thoracic and Cardiovascular Surgery Branch
- Chair, Yunnan Anti-Cancer Association Minimally Invasive Chest Tumor Treatment Committee
- Chair, Lung Cancer Professional Committee, Yunnan Preventive Medicine Association
- Standing Committee Member, Mediastinal Tumor Professional Committee, China Anti-Cancer Association
Name order: in Chinese the family name comes first (Li Gaofeng). Papers usually list the name as Gaofeng Li or Li G.
Selected publications
68 papers on PubMed matched by name and affiliation; 17 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Thorac Dis, 2026 (senior author): A predictive model for immunotherapy in extensive-stage small cell lung cancer based on peripheral blood. PubMed 42444925
- Front Med (Lausanne), 2025 (senior author): A nomogram for predicting intra-operative conversion to endotracheal intubation during non-intubated spontaneous ventilation anesthesia in pulmonary resection: development of a risk prediction model in hypoxic and high-risk patients. PubMed 41393123
- J Thorac Dis, 2025 (senior author): A novel nomogram for predicting mediastinal lymph node metastasis in non-small cell lung cancer: a retrospective analysis. PubMed 40950899
- Elife, 2024 (senior author): Proteogenomic analysis of air-pollution-associated lung cancer reveals prevention and therapeutic opportunities. PubMed 39432560
- Heliyon, 2024 (senior author): A novel tumor mutation-related long non-coding RNA signature for predicting overall survival and immunotherapy response in lung adenocarcinoma. PubMed 38586420
- Immunotherapy, 2024 (senior author): Serplulimab monotherapy in extensive-stage small-cell lung cancer with brain metastasis: a case report. PubMed 38532729
- Int J Womens Health, 2024 (senior author): The Risk of Cervical Cancer in Women Among Han, Bai, Dai and Hani Ethnic Minorities in Yunnan Province of China. PubMed 38482271
- PeerJ, 2024 (senior author): DLX1 acts as a novel prognostic biomarker involved in immune cell infiltration and tumor progression in lung adenocarcinoma. PubMed 38317839
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion